Starting an Antipsychotic? The First Three Months Are a Critical Window
If you or someone you love is starting an antipsychotic medication, the first three months may be the most important time to watch for metabolic changes — here's what the research says.
Most people assume that if a medication is going to cause side effects, those effects build up slowly over years. When it comes to antipsychotic medications and metabolic health, that assumption may not hold. A growing body of research points to the first 90 days as a uniquely vulnerable window for blood sugar spikes, rapid weight gain, and changes in how the body processes fat and glucose.
Here's what you need to know — whether you're a patient, a caregiver, or simply someone who wants to stay informed.
What Are Antipsychotics, and Who Takes Them?
Antipsychotic medications are prescribed for conditions including schizophrenia, bipolar disorder, and treatment-resistant depression. Some are also used at lower doses for anxiety or as sleep aids. They are among the most commonly prescribed psychiatric medications in the United States.
There are two broad categories: older "first-generation" antipsychotics like haloperidol, and newer "second-generation" or atypical antipsychotics such as olanzapine, quetiapine, risperidone, aripiprazole, and clozapine. The second-generation drugs are now far more widely used — and they are the ones most consistently linked to metabolic side effects.
Why the First 90 Days Stand Out
Research published in journals including JAMA Psychiatry and Diabetes Care has found that significant weight gain and blood sugar dysregulation can begin within weeks of starting certain antipsychotics — not after years of use.
Studies of patients starting olanzapine, one of the most metabolically active antipsychotics, have documented meaningful weight gain in as little as six to eight weeks. Some research has found that a substantial portion of the total weight gained over years of treatment may occur in just the first few months.
Blood sugar changes can be just as rapid. Some studies have documented new-onset hyperglycemia — abnormally high blood sugar — appearing within weeks of starting treatment, even in patients with no prior history of diabetes or pre-diabetes. This is why many experts in psychiatry and endocrinology now call the early treatment period a critical metabolic window.
What's Actually Happening Inside the Body
Researchers believe several mechanisms are at work. Second-generation antipsychotics appear to affect receptors in the brain that regulate appetite and satiety, leading many patients to feel significantly hungrier than before. The drugs may also directly interfere with how the body uses insulin, independent of weight gain.
That last point is important. Some studies suggest that antipsychotics can impair insulin sensitivity even before substantial weight gain occurs, which means the metabolic risk isn't just about eating more or moving less — it may be a direct pharmacological effect of the medication itself.
Not all antipsychotics carry the same level of risk. Olanzapine and clozapine are consistently associated with the greatest metabolic effects. Aripiprazole and ziprasidone tend to show lower risk in comparison, though individual responses vary and no medication in this class is entirely free of metabolic concern.
Who Is Most at Risk
Research suggests that people who are younger, those who are starting antipsychotics for the first time, and those who already have risk factors for type 2 diabetes or obesity face the greatest metabolic vulnerability during early treatment.
Studies involving adolescents and young adults have been particularly striking, showing rapid and significant weight gain in some cases within the first weeks. For this age group, early monitoring is especially important.
Family history of diabetes, a higher starting body weight, and a sedentary lifestyle are also factors that may amplify risk. Again, these patterns suggest the importance of individualized monitoring rather than a one-size-fits-all approach.
What Monitoring Should Look Like
Major medical organizations, including the American Diabetes Association and the American Psychiatric Association, have issued joint guidelines recommending metabolic monitoring for patients on antipsychotic medications. The recommended checks include baseline measurements before starting the medication and follow-up monitoring at 12 weeks, then periodically after that.
Those baseline and follow-up measurements typically include body weight and BMI, fasting blood glucose, hemoglobin A1c (a measure of average blood sugar over time), fasting lipids (cholesterol and triglycerides), and blood pressure.
Despite these guidelines, research has consistently found that metabolic monitoring in real-world psychiatric care is underused. If you or a family member is starting an antipsychotic, it is worth asking the prescribing physician about a monitoring plan — and making sure that plan includes those early check-ins within the first three months.
What Patients and Families Can Do
Lifestyle strategies are not a replacement for medication or medical supervision, but research does suggest they can help mitigate metabolic risk during the early treatment period.
- Move more, starting early. Studies suggest that regular physical activity can help offset some of the weight gain and insulin resistance associated with antipsychotic use. Even walking 20 to 30 minutes most days may make a difference.
- Pay attention to appetite changes. If hunger increases significantly after starting a new medication, that's worth noting and discussing with the prescribing doctor. It's not a willpower problem — it may be a drug effect.
- Watch what's on the plate. A diet lower in refined carbohydrates and added sugars supports stable blood sugar, which matters more than ever during this period.
- Track weight at home. Weighing yourself once a week and noting any rapid changes gives you and your doctor useful early information.
- Never stop or change a psychiatric medication on your own. If you have concerns about side effects, talk with your prescribing doctor before making any changes. Stopping antipsychotics abruptly can be dangerous.
The Bottom Line
The first 90 days on an antipsychotic medication may be the most important window for catching and managing metabolic side effects like weight gain and blood sugar changes — and research suggests those changes can happen faster than most people expect. If you or a family member is starting one of these medications, ask the prescribing doctor about a metabolic monitoring plan that includes early check-ins. Staying informed and staying in close contact with your healthcare team during those first three months could make a meaningful difference for long-term health.
***
Feel Amazing Daily is published by Keith Ablow, MD, and Kathryn Munoz, PhD, MPH. Our mission is to translate the latest research in medicine, nutrition, and wellness into clear, practical guidance for health-conscious adults. The information provided here is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider with any questions you may have regarding a medical condition or before making changes to your health regimen.
